These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 27483249

  • 21. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W, Li H, Liu H, Ma X, Yang S, Wang Z.
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [Abstract] [Full Text] [Related]

  • 22. RIP1 upregulation promoted tumor progression by activating AKT/Bcl-2/BAX signaling and predicted poor postsurgical prognosis in HCC.
    Wang C, Yao B, Xu M, Zheng X.
    Tumour Biol; 2016 Nov; 37(11):15305-15313. PubMed ID: 27699664
    [Abstract] [Full Text] [Related]

  • 23. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J, Jing Y, Dong Q, Huan L, Chen D, Bao C, Wang Q, Zhao F, Li J, Yao M, Qin L, Liang L, He X.
    Oncotarget; 2016 Jan 19; 7(3):2672-83. PubMed ID: 26684241
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
    Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y, Liu Q.
    Int J Mol Sci; 2014 Nov 07; 15(11):20486-99. PubMed ID: 25387077
    [Abstract] [Full Text] [Related]

  • 25. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
    Yang Y, Zhao LH, Huang B, Wang RY, Yuan SX, Tao QF, Xu Y, Sun HY, Lin C, Zhou WP.
    Mol Carcinog; 2015 Dec 07; 54(12):1584-95. PubMed ID: 25307746
    [Abstract] [Full Text] [Related]

  • 26. PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/β-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis.
    Zuo Q, He J, Zhang S, Wang H, Jin G, Jin H, Cheng Z, Tao X, Yu C, Li B, Yang C, Wang S, Lv Y, Zhao F, Yao M, Cong W, Wang C, Qin W.
    Hepatology; 2021 Feb 07; 73(2):644-660. PubMed ID: 32298475
    [Abstract] [Full Text] [Related]

  • 27. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J.
    Br J Cancer; 2012 Apr 24; 106(9):1486-94. PubMed ID: 22472882
    [Abstract] [Full Text] [Related]

  • 28. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma.
    Cui M, Sun J, Hou J, Fang T, Wang X, Ge C, Zhao F, Chen T, Xie H, Cui Y, Yao M, Li J, Li H.
    Tumour Biol; 2016 Oct 24; 37(10):13521-13531. PubMed ID: 27465557
    [Abstract] [Full Text] [Related]

  • 29. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW.
    Biomed Pharmacother; 2018 Jul 24; 103():272-283. PubMed ID: 29656183
    [Abstract] [Full Text] [Related]

  • 30. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARγ pathway in hepatocellular carcinoma.
    Li X, Zhao Q, Qi J, Wang W, Zhang D, Li Z, Qin C.
    Int J Oncol; 2018 Aug 24; 53(2):551-566. PubMed ID: 29845188
    [Abstract] [Full Text] [Related]

  • 31. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
    Poon RT, Lau CP, Ho JW, Yu WC, Fan ST, Wong J.
    Clin Cancer Res; 2003 Nov 01; 9(14):5339-45. PubMed ID: 14614019
    [Abstract] [Full Text] [Related]

  • 32. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
    Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ.
    Cancer Res; 2005 Mar 15; 65(6):2251-9. PubMed ID: 15781638
    [Abstract] [Full Text] [Related]

  • 33. LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma.
    Shao B, Zhao X, Liu T, Zhang Y, Sun R, Dong X, Liu F, Zhao N, Zhang D, Wu L, Wang Y, Wang M, Meng J, Lin X, Sun B.
    J Cell Mol Med; 2019 Feb 15; 23(2):1363-1374. PubMed ID: 30506621
    [Abstract] [Full Text] [Related]

  • 34. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
    Hu TH, Huang CC, Lin PR, Chang HW, Ger LP, Lin YW, Changchien CS, Lee CM, Tai MH.
    Cancer; 2003 Apr 15; 97(8):1929-40. PubMed ID: 12673720
    [Abstract] [Full Text] [Related]

  • 35. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF, Zhao J, Hao Y, Li X, Lowe AW, Cheng AS, Sung JJ, Yu J.
    Cancer; 2013 Mar 15; 119(6):1217-26. PubMed ID: 23212831
    [Abstract] [Full Text] [Related]

  • 36. TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.
    Duan M, Wang ZC, Wang XY, Shi JY, Yang LX, Ding ZB, Gao Q, Zhou J, Fan J.
    Ann Surg Oncol; 2015 Sep 15; 22(9):3121-9. PubMed ID: 25465376
    [Abstract] [Full Text] [Related]

  • 37. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ.
    Hepatology; 2010 Jun 15; 51(6):2008-19. PubMed ID: 20512989
    [Abstract] [Full Text] [Related]

  • 38. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
    Wang F, Feng Y, Li P, Wang K, Feng L, Liu YF, Huang H, Guo YB, Mao QS, Xue WJ.
    Oncotarget; 2016 Jan 26; 7(4):4279-97. PubMed ID: 26701853
    [Abstract] [Full Text] [Related]

  • 39. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma.
    He G, Hu S, Zhang D, Wu P, Zhu X, Xin S, Lu G, Ding Y, Liang L.
    Exp Mol Pathol; 2015 Oct 26; 99(2):374-82. PubMed ID: 26112097
    [Abstract] [Full Text] [Related]

  • 40. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis.
    Li R, Wang Y, Zhang X, Feng M, Ma J, Li J, Yang X, Fang F, Xia Q, Zhang Z, Shang M, Jiang S.
    Mol Cancer; 2019 Jan 31; 18(1):18. PubMed ID: 30704479
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.